CDH2 and cancer: At univariable cox regression analyses, expression of N-cadherin was associated with higher probability of recurrence (HR 1.44, 95% CI 1.07–1.95, p = 0.016), but not overall mortality (p = 0.9) or cancer-specific mortality (p = 0.06).